US20080242561A1 - Massively parallel synthesis of biopolymeric arrays - Google Patents

Massively parallel synthesis of biopolymeric arrays Download PDF

Info

Publication number
US20080242561A1
US20080242561A1 US12/133,219 US13321908A US2008242561A1 US 20080242561 A1 US20080242561 A1 US 20080242561A1 US 13321908 A US13321908 A US 13321908A US 2008242561 A1 US2008242561 A1 US 2008242561A1
Authority
US
United States
Prior art keywords
peptide bond
forming
group
molecule
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/133,219
Inventor
John J. Rajasekaran
Edelmira Cabezas
Jacqueline A. Fidanza
Gunjan Tiwari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/133,219 priority Critical patent/US20080242561A1/en
Publication of US20080242561A1 publication Critical patent/US20080242561A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries

Definitions

  • the present invention relates generally to semiconductor lithographic technology, microarrays of bio-polymers, and synthetic organic chemistry.
  • Microarrays of oligonucleotides, peptides, proteins, and or oligosaccharides continue to gain importance as powerful tools for research and diagnostic applications in the biomedical sciences.
  • Oligonucleotide microarrays for example, can be used to monitor gene expression and genetic mutations in a massively parallel manner.
  • Proteinaceous microarrays provide the ability, for example, to characterize the molecular progression of disease, research cellular pathways, and perform high throughput screening in drug discovery applications.
  • Peptide-containing arrays can serve as molecular probes for a variety of biological events, such as for example, the arrays can serve as antigens for antibody-antigen systems, ligands for cell receptor-ligand systems, and substrates for enzyme-protein systems.
  • FIGS. 1A through 1F demonstrate a method for the controllable synthesis of polymers on a solid support involving semiconductor lithographic technology.
  • FIG. 2 provides chemical structure diagrams for exemplary molecules and functional groups.
  • FIG. 3 shows a method for derivatizing a SiO 2 surface and attaching a linker molecule to the derivatized surface.
  • FIG. 4 demonstrates general methods for solid phase peptide synthesis.
  • FIG. 5 demonstrates a general method for the synthesis of branched proteinaceous molecules on a solid surface that can be used to create arrays of molecules.
  • FIGS. 6A-6C provide exemplary bifurcation molecules.
  • FIG. 7 outlines an additional method for the synthesis of branched proteinaceous molecules on a solid surface that can be used to create arrays of biomolecules.
  • FIG. 8 diagrams the effect of the application of microwave energy to a substrate surface having attached polymers.
  • FIG. 9 diagrams the use of microwave energy in the photoresist method for peptide parallel synthesis.
  • An array is an intentionally-created collection of molecules housed on a solid support in which the identity or source of a group of molecules is known based on its location on the array.
  • the molecules housed on the array and within a feature of an array can be identical to or different from each other.
  • Embodiments of the present invention provide methods for the synthesis of polymers on a solid support. Polymer synthesis according to embodiments of the invention can be accomplished in a manner that provides controlled-density microarrays comprised of peptides, peptoids, peptidemimetics, branched peptides, and or other small bio-molecules.
  • Embodiments of the present invention provide arrays of biopolymers of known sequence and controllable molecular density. Additionally, the methods described in embodiments of the invention are highly scalable for array manufacture on a wafer or chip as are used in to fabricated devices in the semiconductor industry.
  • the features, regions, or sectors of an array in which the bio-polymers are located may have any convenient shape, for example, the features of the array may be circular, square, rectangular, elliptical, or wedge-shaped.
  • the region in which each distinct biomolecule is synthesized within a feature is smaller than about 1 mm 2 , or less than 0.5 mm 2 .
  • the features have an area less than about 10,000 ⁇ m 2 or less than 2.5 ⁇ m 2 .
  • multiple copies of a polymer will typically be located within any feature. The number of copies of a polymer can be in the thousands to the millions within a feature.
  • an array can have any number of features, and the number of features contained in an array may be selected to address such considerations as, for example, experimental objectives, information-gathering objectives, and cost effectiveness.
  • An array could be, for example, a 20 ⁇ 20 matrix having 400 regions, 64 ⁇ 32 matrix having 2,048 regions, or a 640 ⁇ 320 array having 204,800 regions.
  • the present invention is not limited to a particular size or configuration for the array.
  • FIGS. 1A-F A method for synthesizing unbranched polymers within one or more selected region(s) of a solid support is shown in FIGS. 1A-F .
  • the method includes attachment of a first amino acid, linker (or spacer) molecule, or other building block 2 to the surface of a substrate 1 .
  • a first building block 2 can be an amino acid that is attached to a substrate 1 that is comprised of amino-functionalized glass, through the formation of a peptide bond between the carboxylate of the amino acid and the amine group of the glass.
  • the terminal bond-forming site of the building block 2 is protected with a protecting group 3 .
  • the ⁇ -amino group of an amino acid can be protected with an N-protecting group 3 to prevent unwanted reactivity.
  • a side chain of the building block (for example, an R group of an amino acid) may also have a protecting group.
  • Suitable protecting groups include, for example, t-butoxycarbonyl (t-BOC) ( FIG. 2 , structure (II)), and fluorenylmethoxycarbonyl (FMOC) ( FIG. 2 , Structure (III), and 2-(4-biphenylyl)-2-oxycarbonyl.
  • embodiments of the present invention are not limited to the type of acid- or base-removable protective group or building block selected.
  • the photoresist layer can be created from a solution comprising a polymer, a photosensitizer, and a photo-active compound or molecule in a solvent.
  • the photoresist can be applied using any method known in the art of semiconductor manufacturing for the coating of a wafer with a photoresist layer, such as for example, the spin-coating method.
  • the photoresist-coated substrate is then baked to remove excess solvent from the photoresist and for film uniformity.
  • a photomask 5 is placed over photoresist layer 4 .
  • the photomask use may be practiced according to standard techniques and materials used in the semiconductor fabrication industry.
  • the photomask 5 may be a transparent pane, such as a quartz pane, having an emulsion or metal film on a surface creating the mask pattern. Suitable metals include chromium.
  • the pattern of the mask is chosen so that regions on the surface of the substrate can be selectively activated for polymer synthesis. Radiation, for example, ultra violet radiation (UV) or deep ultraviolet radiation (DUV), may then be directed through the photomask 5 onto the photoresist layer.
  • the photoresist 4 is exposed in those regions of the mask that are transparent to the impinging radiation.
  • the device used for creating a pattern in the photoresist can be a physical mask or any other source capable of projecting a pattern image, for example a micromirror.
  • the exposure of the photoresist 4 to radiation generates cleaving reagents (species that catalyze the removal of a protective group, for example) in the exposed portion of the photoresist layer 4 .
  • the generation of cleaving reagents in the photoresist may be the result of a number of processes.
  • the cleaving reagent may result from the direct radiation-induced decomposition of or chemical transformation of a photoactive cleavage reagent precursor compound.
  • generation of the cleaving reagent may occur through the absorption of light by a photosensitizer followed by reaction of the photosensitizer with the cleavage reagent precursor, energy transfer from the photosensitizer to the cleavage reagent precursor, or a combination of two or more different mechanisms.
  • the protecting groups 3 are cleaved from the molecules 2 under the exposed area(s) of the photoresist.
  • the molecules 2 located under the unexposed masked regions remain unreacted.
  • the cleaving process leading to the removal of the protecting groups 3 may, for example, be acid-catalyzed cleavage or base-catalyzed cleavage.
  • the chemistry of the process will depend on the type of protecting groups 3 and on the type of cleaving reagents that are generated in the photoresist upon radiation exposure. For example, if the protecting group 3 is t-BOC, acid cleavage can be used.
  • Acids may be generated in the photoresist, for example, through the exposure of sulfonium or halonium salts to radiation ( FIG. 2 , Structures (IV-VII) and (VIII-IX), respectively).
  • the protecting group is FMOC, for example, then base cleavage can be used. Cleavage can be accomplished through the reaction of a photogenerated amine or diamine through a decarboxylation process ( FIG. 5 ).
  • the rate of protecting group removal can be accelerated by heating the substrate after the exposure to radiation (post exposure bake).
  • the post exposure bake serves multiple purposes in photoresist processing. First, the elevated temperature of the bake drives diffusion of the photoproducts.
  • a small amount of diffusion can be useful in minimizing the effects of standing waves, periodic variations in exposure dose throughout the depth of the film that result from interference of incident and reflected radiation.
  • the other main purpose of the PEB is to drive the acid-catalyzed reaction. Chemical amplification is important because it allows a single photoproduct to cause many solubility-switching reactions, thus increasing the sensitivity of these photoresist systems.
  • the photoresist is removed.
  • the photoresist layer 4 may be removed using acetone or another similar suitable solvent.
  • the resulting surface-modified substrate is shown schematically in FIG. 1D .
  • FIG. 1D In this structure, there are three regions shown: two regions that have protected molecules and a region having deprotected molecules.
  • the deprotected molecules are available for further reaction, such as for example, a peptide-bond forming coupling reaction whereas the molecules that retain their protective groups are not available for further reaction.
  • FIG. 1E shows a structure resulting from the reaction of the deprotected surface-attached molecules.
  • a building block 6 has been added to molecule 2 .
  • Building block 6 may be the same or different from molecule 2 .
  • the building block 6 is protected with a protecting group to prevent unwanted reactions.
  • FIGS. 1A-E may be repeated to form polymers on the substrate surface.
  • different polymers comprising building blocks 2 and 6 - 10 may be formed in regions upon the surface, as shown schematically in FIG. 2F .
  • the building blocks are amino acids
  • peptides having the same or different known sequences are formed in known regions on the surface of the substrate.
  • polymers containing from about 2 to about 50 mers (polymeric units) can be created.
  • peptides having a length of about 6 to about 20 amino acids are created.
  • capping reagents can be a reagent that prevents further reactivity at the site of polymer chain formation such as, for example, an acid anhydride without further reactive functionalities.
  • Capping groups cap deprotected functional groups by, for example, binding with the unreacted amino functions to form amides.
  • Capping agents suitable for use in an embodiment of the invention include: acetic anhydride, n-acetylimidizole, isopropenyl formate, fluorescamine, 3-nitrophthalic anhydride and 3-sulfoproponic anhydride.
  • peptides are polymers of amino acids, amino acid mimics or derivatives, and/or unnatural amino acids.
  • the amino acids can be any amino acids, including ⁇ , ⁇ , or ⁇ -amino acids and modified amino acids.
  • the amino acids are ⁇ -amino acids, either the L-optical isomer or the D-optical isomer may be used.
  • FIG. 2 Structure (I), shows a general structural representation for an amino acid.
  • an amino acid contains an amine group, a carboxylic group, and an R group.
  • the R group can be a group found on a natural amino acid or a group that is similar in size to a natural amino acid R group.
  • unnatural amino acids for example, O-alanine, phenylglycine, homoarginine, aminobutyric acid, aminohexanoic acid, aminoisobutyric acid, butylglycine, citrulline, cyclohexylalanine, diaminopropionic acid, hydroxyproline, norleucine, norvaline, ornithine, penicillamine, pyroglutamic acid, sarcosine, and thienylalanine are also contemplated by the embodiments of the invention.
  • These and other natural and unnatural amino acids are available from, for example, EMD Biosciences, Inc., San Diego, Calif.
  • a peptide is a polymer in which the monomers are amino acids, a group of molecules which includes natural or unnatural amino acids, amino acid mimetics, and amino acid derivatives, which are generally joined together through amide (peptide) bonds.
  • a peptide can alternatively be referred to as a polypeptide.
  • Peptides contain two or more amino acid monomers, and often more than 50 amino acid monomers (building blocks).
  • a protein is a long polymer of amino acids linked via peptide bonds and which may be composed of one or more polypeptide chains. More specifically, the term protein refers to a molecule comprised of one or more polymers of amino acids. Proteins are essential for the structure, function, and regulation of the body's cells, tissues, and organs, and each protein has unique functions. Examples of proteins include some hormones, enzymes, and antibodies.
  • a protecting group is a group which is bound to a molecule and designed to block a reactive site in a molecule, but may be removed upon exposure to an activator or a deprotecting reagent.
  • Deprotecting reagents include, for example, acids and bases.
  • Protecting groups can be bound to a monomer, a polymer, a linker molecule or a monomer, or polymer, or a linker molecule attached to a solid support to protect a reactive functionality on the monomer, polymer, or linker molecule.
  • Protective groups that may be used in accordance with an embodiment of the invention include all acid and base labile protecting groups.
  • peptide amine groups are preferably protected by t-butoxycarbonyl (t-BOC or BOC) (shown in FIG. 1 , Structure (II)) or benzyloxycarbonyl (CBZ), both of which are acid labile, or by 9-fluorenylmethoxycarbonyl (FMOC) (shown in FIG. 1 , Structure (III)), which is base labile.
  • t-BOC or BOC t-butoxycarbonyl
  • BOC benzyloxycarbonyl
  • FMOC 9-fluorenylmethoxycarbonyl
  • Additional protecting groups that may be used in accordance with embodiments of the invention include acid labile groups for protecting amino moieties: tert-amyloxycarbonyl, adamantyloxycarbonyl, 1-methylcyclobutyloxycarbonyl, 2-(p-biphenyl)propyl(2)oxycarbonyl, 2-(p-phenylazophenylyl)propyl(2)oxycarbonyl, .alpha.,.alpha.-dimethyl-3,5-dimethyloxybenzyloxy-carbonyl, 2-phenylpropyl(2)oxycarbonyl, 4-methyloxybenzyloxycarbonyl, furfuryloxycarbonyl, triphenylmethyl(trityl), p-toluenesulfenylaminocarbonyl, dimethylphosphinothioyl, diphenylphosphinothioyl, 2-benzoyl-1-methylvinyl, o-nitrophenylsulfenyl, and 1-na
  • a linker molecule typically is a molecule inserted into the growing polymer that does not necessarily convey functionality to the resulting peptide, such as molecular recognition functionality, but instead elongates the distance between the substrate surface and the peptide functionality to enhance the exposure of the peptide functionality on the surface of the substrate.
  • a linker should be about 4 to about 40 atoms long to provide exposure.
  • the linker molecules may be, for example, aryl acetylene, ethylene glycol oligomers containing 2-10 monomer units (PEGs), diamines, diacids, amino acids, among others, and combinations thereof. Examples of diamines include ethylene diamine and diamino propane.
  • the linkers may be the same molecule type as that being synthesized (i.e., nascent polymers), such as polypeptides and polymers of amino acid derivatives such as for example, amino hexanoic acids.
  • Solid support, support, and substrate refer to a material or group of materials having a rigid or semi-rigid surface or surfaces. In some aspects, at least one surface of the solid support will be substantially flat, although in some aspects it may be desirable to physically separate synthesis regions for different molecules with, for example, wells, raised regions, pins, etched trenches, or the like. In certain embodiments, the solid support may be porous.
  • Substrate materials useful in embodiments of the present invention include, for example, silicon, bio-compatible polymers such as, for example poly(methyl methacrylate) (PMMA) and polydimethylsiloxane (PDMS), glass, SiO 2 (such as, for example, a thermal oxide silicon wafer such as that used by the semiconductor industry), quartz, silicon nitride, functionalized glass, gold, platinum, and aluminum.
  • Functionalized surfaces include for example, amino-functionalized glass, carboxy functionalized glass, and hydroxy functionalized glass.
  • a substrate may optionally be coated with one or more layers to provide a surface for molecular attachment or functionalization, increased or decreased reactivity, binding detection, or other specialized application.
  • Substrate materials and or layer(s) may be porous or non-porous.
  • a substrate may be comprised of porous silicon.
  • the substrate may be a silicon wafer or chip such as those used in the semiconductor device fabrication industry. In the case of a wafer or chip, a plurality of arrays may be synthesized on the wafer.
  • Photoresist formulations useful in the present invention include a polymer, a solvent, and a radiation-activated cleaving reagent.
  • Useful polymers include, for example, poly(methyl methacrylate) (PMMA), poly-(methyl isopropenyl ketone) (PMPIK), poly-(butene-1-sulfone) (PBS), poly-(trifluoroethyl chloroacrylate) (TFECA), copolymer-( ⁇ -cyano ethyl acrylate- ⁇ -amido ethyl acrylate (COP), and poly-(2-methyl pentene-1-sulfone).
  • Useful solvents include, for example, propylene glycol methyl ether acetate (PGMEA), ethyl lactate, and ethoxyethyl acetate.
  • the solvent used in fabricating the photoresist may be selected depending on the particular polymer, photosensitizer, and photo-active compound that are selected.
  • the polymer used in the photoresist is PMMA
  • the photosensitizer is isopropyl-thioxanthenone
  • the photoactive compound is diphenyliodonium chloride
  • PGMEA or ethyl lactate may be used as the solvent.
  • the mass concentration of the polymer may between about 5% and about 50%, the mass concentration of a photosensitizer may be up to about 20%, the mass concentration of the photo-active compound may be between about 1% and 10%, the balance comprising a suitable solvent.
  • the substrate typically is heated to form the photoresist layer. Any method known in the art of semiconductor fabrication may be used to for depositing the photoresist solution. For example, the spin coating method may be used in which the substrate is spun typically at speeds between about 1,000 and about 5,000 revolutions per minute for about 30 to about 60 seconds.
  • the resulting wet photoresist layer has a thickness ranging between about 0.1 ⁇ m to about 2.5 ⁇ m.
  • Catalysts for protective group removal include acids and bases.
  • acids can be generated photochemically from sulfonium salts ( FIG. 2 , Structures IV-VII), halonium salts ( FIG. 2 , Structures VIII-IX), and polonium salts ( FIG. 2 , Structures X-XI).
  • Sulfonium ions are positive ions, R 3 S + , where R is, for example, a hydrogen or alkyl group, such as methyl, phenyl, or other aryl group.
  • Trimethyl sulfonium iodide and triaryl sulfonium hexafluoroantimonatate are shown in FIG. 2 , Structures VII and VI, respectively.
  • halonium ions are bivalent halogens, R 2 X + , where R is a hydrogen or an alkyl group, such as methyl, phenyl, or other aryl group, and X is a halogen atom.
  • the halonium ion may be linear or cyclic.
  • Polonium salt refers to a halonium salt where the halogen is iodine, the compound R 2 I + Y ⁇ , where Y is an anion, for example, a nitrate, chloride, or bromide.
  • FIG. 2 shows diphenyliodonium chloride and diphenyliodonium nitrate (Structure X and XI, respectively). See also, Frechet, J. M. J., Ito, H., Willson, C. G., Proc. Microcircuit Eng., 260, (1982); Shirai, M., Tsunooka, M., Prog. Polym. Sci., 21:1, (1996); Frechet, J. M.
  • Photogenerated bases include amines and diamines having photolabile protecting groups. See for example, Shirai, M., Tsunooka, M., Prog. Polym. Sci., 21:1, (1996); Comeron, J. F., Frechet, J. M. J., J. Org. Chem., 55:5919, (1990); Comeron, J. F., Frechet, J. M. J., J. Am. Chem. Soc., 113:4303, (1991); and Arimitsu, K. and Ichimura, K., J. Mat. Chem., 14:336, (2004).
  • the photoresists useful in the present invention may also include a photosensitizer.
  • a photosensitizer absorbs light and interacts with the cleavage reagent precursor, through one or more mechanisms, including, reaction with the cleavage reagent precursor and energy transfer from the photosensitizer to the cleavage reagent precursor.
  • Useful photosensitizers include, for example, benzophenone ( FIG. 2 , Structure XII) and other similar diphenyl ketones, thioxanthenone ( FIG. 2 , Structure XIII), isopropyl-thioxanthenone, anthraquinone, fluorenone, acetophenone, and perylene.
  • FIG. 3 provides a method for derivatization of a SiO 2 surface and linking of polymeric molecules to the surface.
  • the SiO 2 surface is silanated by reacting it with aminopropyltriethoxy silane (APTES).
  • APTES aminopropyltriethoxy silane
  • the resulting surface presents an amine functional group for further reaction, such as peptide bond formation.
  • Modulation of the density of polymers on the surface can be attained by silanation. For example, density can be modulated by mixing a functionalizable silane for example.
  • APTES with a non-functional silane (a silane with no non silyl functional group), for example, propyltrialkoxy silane.
  • the derivatized surface can then be reacted with a linker.
  • the linker is a polyethylene glycol molecule having an amine group protected with BOC at one terminus and a peptide-bond forming group (a carboxyl group) at the second terminus.
  • This coupling reaction can be accomplished in a solution of carboxyl group activators: 1-hydroxybenzotriazole (HOBt) and diisopropylcarbodiimide (DIC) in N-methylpyrrolidone (NMP).
  • HOBt 1-hydroxybenzotriazole
  • DIC diisopropylcarbodiimide
  • NMP N-methylpyrrolidone
  • FIG. 4 shows a general scheme for solid-phase peptide synthesis.
  • a substrate surface is provided having a first amino acid attached to the surface.
  • a second amino acid having an amino protecting group is coupled to the first amino acid.
  • the second amino acid is N-protected with a BOC protecting group.
  • the coupling reaction is performed in a solution of 1-hydroxybenzotriazole (HOBt) and diisopropylcarbodiimide (DIC) in N-methylpyrrolidone (NMP). Unreacted amine groups are capped using an acetic anhydride (Ac 2 O) solution in dimethylformamide (DMF).
  • the substrate surface is then coated with a photoresist.
  • the photoresist is comprised of PMMA polymer, TASSbF 6 (photoactivated acid generator), and PGMEA (as a solvent).
  • TFA represents trifluoroacetic acid, the acidic cleaving reagent typically used for bulk solid-phase peptide synthesis.
  • yields for a peptide synthesis process according to the current invention were similar to yields for bulk solid-phase synthesis procedures using TFA as a protecting group removal catalyst.
  • UV radiation an acid is produced in the photoresist and the N-protecting group is removed from the attached peptide in the region of UV exposure.
  • FIG. 5 diagrams a method for using semiconductor photoresist acid and base cleavage mechanisms and orthogonal protection chemistries to create a branch point in a growing solid-phase polymer chain.
  • a region of a substrate surface presents an attached amino acid building block containing an acid-cleavable protecting group that prevents the formation of a peptide bond.
  • the amino acid building block may be attached to the surface through a linker molecule that spaces the amino acid from the surface and or that functions as a peptide or peptidemimetic.
  • the substrate surface is coated with an acid-generating photoresist and at least one region of the substrate surface is exposed to radiation to induce the formation of the photo-generated acid in the photoresist.
  • a mask is used to selectively block the radiation from areas of the substrate surface and thereby cause deprotection of only molecules located in selected regions of the substrate surface.
  • the substrate surface is subjected to a post-exposure bake.
  • the photoresist is then stripped from the substrate surface leaving a section(s) of the substrate having deprotected sites available for the formation of peptide bonds.
  • a bifurcation group is coupled to the deprotected growing chain.
  • the bifurcation group contains both acid and base cleavable protecting groups.
  • the branch points of the bifurcation group can be selectively deprotected by selecting either an acid or a base-generating photoresist. In the scheme shown in FIG.
  • a base-generating photoresist is selected and the base-cleavable protecting group is removed from the bifurcation group upon irradiation.
  • the surface is baked and the resist removed.
  • An amino acid having a base-removable protecting group is coupled to the bifurcation group at the point in which the base-removable group was removed.
  • the acid labile protecting group may be removed in a similar manner using a photoresist containing a photogenerated acid as described herein.
  • An amino acid having an acid-removable protecting group is then coupled to the bifurcation group. Repetitions of these acid or base deprotection-coupling events allow a branched polymer having a desired sequence to be synthesized.
  • the polymers formed from the branch-point may be the same or different lengths.
  • optionally polymers having one or more branch points may be created.
  • An array may be created having both branched and unbranched polymers in regions upon its surface.
  • a bifurcation molecule is a molecule that when it is attached to a growing polymer provides more than one location for further polymer growth or extension.
  • a bifurcation molecule is a polymeric building block that creates a branch point in a polymer.
  • FIGS. 6A-C provide several exemplary bifurcation molecules: FIG. 6A shows Trt-Dpr(Fmoc)-OH (Dpr is diaminopropionic acid); FIG. 6B shows Fmoc-Dab(Mtt)-OH (“Dab” is diaminobutanoic acid, “Mtt” is 4-methyltrityl, an acid-removable protecting group); FIG.
  • bifurcation molecules include Fmoc-Dpr(Boc)-OH, Fmoc-Dab(Boc)-OH, or any of the previous amino acids having the same protecting group at the amino and the side chain functionalities (to allow growth of two peptide chains having the same sequence), such as for example, Fmoc-Dpr(Fmoc)-OH or Trt-Dpr(Trt)-OH.
  • Fmoc-Dpr(Fmoc)-OH or Trt-Dpr(Trt)-OH are available from EMD Biosciences Nova Biochem, La Jolla, Calif.; Bachem, Torrance, Calif.; and Chem-Impex International.
  • FIG. 7 diagrams a further method by which branch points can be created in a polymer using orthogonal protection strategies and solid-phase bio-polymer synthesis.
  • direct photo-cleavage lithography is applied to the synthesis of a branched peptide array.
  • a region of a substrate surface presents an attached amino acid building block containing a photo-cleavable protecting group that prevents the formation of a peptide bond.
  • the amino acid building block may be attached to the surface through a linker molecule that spaces the amino acid from the surface and or that functions as a peptide or peptidemimetic.
  • the photo-cleavable protecting group is removable at a first wavelength, ⁇ 1 .
  • Exposing the substrate through a mask to radiation at a first wavelength, ⁇ 1 removes the protecting group in selected regions.
  • a bifurcation group having photo-cleavable protecting groups that are removable at two different wavelengths, ⁇ 1 and ⁇ 2 is coupled to the photo-deprotected amino acid building blocks.
  • a selected area(s) of the substrate surface are exposed to light of wavelength ⁇ 2 and the ⁇ 2 photo-removable protecting group is removed.
  • An amino acid building block having a ⁇ 2 photo-removable protecting group is coupled to the deprotected site of the bifurcation group.
  • a selected area(s) of the substrate surface are exposed to light of wavelength ⁇ 1 and the ⁇ 1 photo-removable protecting group is removed.
  • An amino acid building block having a ⁇ 1 photo-removable protecting group is coupled to the deprotected site of the bifurcation group. Repetitions of these photo-deprotection-coupling events allow a branched polymer having a desired sequence to be synthesized.
  • the polymers formed from the branch-point may be the same or different lengths. Additionally, optionally polymers having one or more branch points may be created.
  • An array may be created having both branched and unbranched polymers in regions upon its surface.
  • wavelength controlled orthogonal protecting groups are described in “Wavelength-Controlled Orthogonal Photolysis of Protecting Groups,” Blanc, A. and Bochte, C., J. Org. Chem., 67:5567 (2002). Additional examples of photo-cleavable protecting groups can be found in: Photogenerated Reagents in Biochemistry and Molecular Biology , Bayley, H., Laboratory Techniques in Biochemistry and Molecular Biology, 12, Elsevier (2002); and Clark, M. A. and Romoff, T. T., Synthesis of peptides and peptidomimetics, Methods of Organic Chemistry, E 22a:276 (2004). The most common photocleavable groups are 2-nitrobenzyl-derived carbamates, esters, and ethers.
  • Examples include Z(2-NO2), Nvoc, Ndmoc, Dnboc, Menpoc, Ddz.
  • Other examples include tosyl, phenacyl-based esters, and the 5-bromo-7-nitro-indolinyl group.
  • Many amino acids with photocleavable protecting groups are available from Chem-Impex International, Wood Dale, Ill.
  • methods are provided to synthesize biopolymers on an array wherein the synthesis is assisted by microwave radiation.
  • Organic synthesis reactions that are assisted by microwave radiation generally demonstrate faster rates and improved fidelity.
  • Synthesis of biopolymers, particularly parallel synthesis methodologies can encounter difficulties, depending on the species being synthesized, from intermolecular aggregation, hydrogen bonded secondary structures (such as, for example, beta-sheet formation in peptides), steric hindrance from bulky side chain protecting groups, and hence premature termination of the sequence.
  • FIG. 8 a schematic is presented showing the microwave heating of polymers on a substrate surface. In this example, the heating of the polymers causes them to unwind.
  • microwave energy directly activates any molecule with a dipole moment and allows for local heating at a molecular level.
  • intermolecular and intramolecular aggregation, secondary structure formation, and steric hindrance can be overcome with microwave energy.
  • reaction times for deprotection and coupling reactions can be reduced and fidelity of lithographic techniques can be enhanced.
  • FIG. 9 shows the use of microwave energy to assist the synthesis of biopolymers on a solid support.
  • microwave energy can be used to facilitate the synthesis of branched and unbranched biopolymers, such as for example, peptides, peptidemimetics, and polynucleotides, by photoresist methods and methods employing photo-removable protecting groups, as described herein and as known in the art.
  • polynucleotide includes oligonucleotides, peptide nucleic acids (PNAs), and cDNA.
  • a substrate surface presents attached biopolymer building blocks having a protecting group that prevents polymer formation. The substrate is coated with a photoresist.
  • Synthesizers generally supply microwave power of about 25 to 50 W and a temperature range of 20 to 70° C. Additionally, microwave energy can be employed in the manufacture of arrays on silicon chips. In this case a microwave stepper and a microwave synthesizer can be used to manufacture a plurality of arrays in a similar manner as it is employed in the semiconductor fabrication industry.
  • a glass substrate was silanated using a solution of 3% APTES (aminopropyl triethoxy silane) in 95% ethanol. The surface of the substrate was then washed and annealed at about 100° C. for about 1 hour. The substrate was then treated with a 1:1 solution of DIEA (diisopropyl ethyl amine) in DMF (dimethylformamide).
  • APTES aminopropyl triethoxy silane
  • a spacer molecule was then coupled to the surface using a solution of 0.25 M solution of O—(N-Boc-2-aminoethyl)-O′—(N-diglycolyl-2-aminoethyl) hexaethyleneglycol, 0.25 M HOBt, and 0.25 M DIC (diisopropylcarbodiimide) in NMP (N-methyl pyrrolidone) and gentle agitation over the surface of the substrate in a sealed container for about 30 min. The solution was then discarded and the surface replenished with fresh solution. After coupling was complete, the surface was washed with NMP and then acetone. Unreacted surface amine groups were capped by treatment with 1:1 acetic anhydride in DMF solution (a 50% acetic anhydride solution in DMF) for about 30 minutes. The surface was then washed.
  • a photoresist was prepared by mixing about 10% by mass of PMMA, 20% by mass of triarylsulfonium hexafluoroantimonate in PGMEA solvent and spin coating the mixture over the amino acid derivatized glass surface for about 60 seconds at 2,000 rpm.
  • the photoresist may also optionally contain thioxanthenone, a photosensitizer.
  • the photoresist layer was baked at about 85° C. for about 90 seconds. The resulting photoresist layer had a thickness of about 2 ⁇ m.
  • Acid was generated in the photoresist layer by irradiation of the surface of the substrate with 2-3 J of 365 nm UV light through a mask. The reaction was accelerated by a post exposure bake at about 65° C. for about 60 seconds. After the photogenerated acid deprotection was achieved, the surface of the substrate was rinsed with acetone to strip the photoresist from the surface and the surface was dried. The surface was neutralized by treatment in 25% DIEA/DMF for about 5-10 minutes and then washed in DMF.
  • a second amino acid (Boc-Leu-OH) was coupled to the surface of the substrate using a 0.25 M solution of N- ⁇ -Boc-Leu, HOBt, and DIC as above. Subsequent rounds of coupling and deprotection were accomplished by repeating the above procedures to generate peptides of a desired length.
  • a hexamer peptide, SDLYKL segment of human tumor suppressor protein p53 was synthesized on an APTES surface derivatized with a PEG (polyethylene glycol) spacer.
  • a labeled F1-tagged anti-p53 monoclonal antibody in a standard Ab binding assay recognized and strongly bound to the SDLYLK peptide on the surface as determined by fluorescence detection.
  • the peptide array was incubated for 1 hour with 5 ⁇ g/ml monoclonal antibody known to specifically recognize the SDLHKL epitope of human p53 protein. A second incubation was performed with fluorescein-labeled rabbit antibody raised against mouse antibody at a 1:100 dilution in phosphate buffered saline with 0.05% Tween 20 . A fluorescent checker board pattern was detected on fluorescence scanning of the array suggesting specific interaction of antibody with the wildtype sequence.
  • Photoresist formulations may include a sensitizer in addition to the photogenerated acid catalyst to generate the acid deprotection catalysts.
  • the amount of PMMA in the resist in these exemplary formulations may vary between about 3% and about 50%.
  • Useful photoresists may be made using diaryliodonium salts (DAI) and photosensitizers.
  • the mass ration between DAI and photosensitizer may be between about 1:10 and 1:1.
  • DAI diaryliodonium salts
  • Photosensitizers may be between about 1:10 and 1:1.
  • (tolylcumyl)polonium tetrakis(pentafluorophenyl) borate with isopropyl-9H-thioxanthen-9-one may be formulated in a 1:10 or 1:1 (or a ratio there between) in PMMA and PGMEA to form final concentrations of between about 0.5% to 10% by mass DAI.
  • the formulation selected may be spun coated on the substrate surface and baked.
  • the radiation exposure dose may be between about 0.02 J and about 10 J.
  • Post exposure baking may be conducted for about 30 to 60 seconds at about 40° C. to about 85° C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Methods for fabricating dense arrays of polymeric molecules in a highly multiplexed manner are provided using semiconductor-processing-derived lithographic methods. Advantageously, the methods are adaptable to the synthesis of a variety of polymeric compounds. For example, arrays of branched peptides and polymers joined by peptide bonds may be fabricated in a highly multiplexed manner.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates generally to semiconductor lithographic technology, microarrays of bio-polymers, and synthetic organic chemistry.
  • 2. Background Information
  • Microarrays of oligonucleotides, peptides, proteins, and or oligosaccharides continue to gain importance as powerful tools for research and diagnostic applications in the biomedical sciences. Oligonucleotide microarrays, for example, can be used to monitor gene expression and genetic mutations in a massively parallel manner. Proteinaceous microarrays provide the ability, for example, to characterize the molecular progression of disease, research cellular pathways, and perform high throughput screening in drug discovery applications. Peptide-containing arrays can serve as molecular probes for a variety of biological events, such as for example, the arrays can serve as antigens for antibody-antigen systems, ligands for cell receptor-ligand systems, and substrates for enzyme-protein systems. The ability to collect large volumes of information is an integral part of biomarker discovery and personalization of medical treatments. Further, other applications in bioscience, such as for example, the analysis of the proteomic content of an organism, disease detection, pathogen detection, environmental protection, food safety, and biodefense are capable of benefiting from tools that allow rapid multiplexed interrogation of analyte samples.
  • As the genomic and proteomic knowledge base expands and the drive toward personalized medicine continues, so does the need for methods to collect, understand, and apply biologically relevant information. Methods, such as analyses using microarrays that allow the use of small volumes of sample for highly multiplexed analyses, are valuable tools. Thus amplifying the value of methods that provide for the controllable automated manufacture of arrays.
  • BRIEF DESCRIPTION OF THE FIGURES
  • FIGS. 1A through 1F demonstrate a method for the controllable synthesis of polymers on a solid support involving semiconductor lithographic technology.
  • FIG. 2 provides chemical structure diagrams for exemplary molecules and functional groups.
  • FIG. 3 shows a method for derivatizing a SiO2 surface and attaching a linker molecule to the derivatized surface.
  • FIG. 4 demonstrates general methods for solid phase peptide synthesis.
  • FIG. 5 demonstrates a general method for the synthesis of branched proteinaceous molecules on a solid surface that can be used to create arrays of molecules.
  • FIGS. 6A-6C provide exemplary bifurcation molecules.
  • FIG. 7 outlines an additional method for the synthesis of branched proteinaceous molecules on a solid surface that can be used to create arrays of biomolecules.
  • FIG. 8 diagrams the effect of the application of microwave energy to a substrate surface having attached polymers.
  • FIG. 9 diagrams the use of microwave energy in the photoresist method for peptide parallel synthesis.
  • DETAILED DESCRIPTION OF THE INVENTION
  • An array is an intentionally-created collection of molecules housed on a solid support in which the identity or source of a group of molecules is known based on its location on the array. The molecules housed on the array and within a feature of an array can be identical to or different from each other. Embodiments of the present invention provide methods for the synthesis of polymers on a solid support. Polymer synthesis according to embodiments of the invention can be accomplished in a manner that provides controlled-density microarrays comprised of peptides, peptoids, peptidemimetics, branched peptides, and or other small bio-molecules. Embodiments of the present invention provide arrays of biopolymers of known sequence and controllable molecular density. Additionally, the methods described in embodiments of the invention are highly scalable for array manufacture on a wafer or chip as are used in to fabricated devices in the semiconductor industry.
  • The features, regions, or sectors of an array in which the bio-polymers are located may have any convenient shape, for example, the features of the array may be circular, square, rectangular, elliptical, or wedge-shaped. In some embodiments, the region in which each distinct biomolecule is synthesized within a feature is smaller than about 1 mm2, or less than 0.5 mm2. In further embodiments the features have an area less than about 10,000 μm2 or less than 2.5 μm2. Additionally, multiple copies of a polymer will typically be located within any feature. The number of copies of a polymer can be in the thousands to the millions within a feature. In general, an array can have any number of features, and the number of features contained in an array may be selected to address such considerations as, for example, experimental objectives, information-gathering objectives, and cost effectiveness. An array could be, for example, a 20×20 matrix having 400 regions, 64×32 matrix having 2,048 regions, or a 640×320 array having 204,800 regions. Advantageously, the present invention is not limited to a particular size or configuration for the array.
  • A method for synthesizing unbranched polymers within one or more selected region(s) of a solid support is shown in FIGS. 1A-F. In general, the method includes attachment of a first amino acid, linker (or spacer) molecule, or other building block 2 to the surface of a substrate 1. Additionally, mixtures of different building blocks 2 may also be used. For example, in FIG. 1A a first building block 2 can be an amino acid that is attached to a substrate 1 that is comprised of amino-functionalized glass, through the formation of a peptide bond between the carboxylate of the amino acid and the amine group of the glass. The terminal bond-forming site of the building block 2 is protected with a protecting group 3. For example, the α-amino group of an amino acid can be protected with an N-protecting group 3 to prevent unwanted reactivity. If necessary, a side chain of the building block (for example, an R group of an amino acid) may also have a protecting group. Suitable protecting groups include, for example, t-butoxycarbonyl (t-BOC) (FIG. 2, structure (II)), and fluorenylmethoxycarbonyl (FMOC) (FIG. 2, Structure (III), and 2-(4-biphenylyl)-2-oxycarbonyl. Advantageously, embodiments of the present invention are not limited to the type of acid- or base-removable protective group or building block selected.
  • Referring now to FIG. 1B, once the first polymer building block has been attached to a substrate, a layer of photoresist 4 is deposited over the substrate 1 surface. In embodiments of the invention, the photoresist layer can be created from a solution comprising a polymer, a photosensitizer, and a photo-active compound or molecule in a solvent. The photoresist can be applied using any method known in the art of semiconductor manufacturing for the coating of a wafer with a photoresist layer, such as for example, the spin-coating method. The photoresist-coated substrate is then baked to remove excess solvent from the photoresist and for film uniformity.
  • In FIG. 1 C, a photomask 5 is placed over photoresist layer 4. The photomask use may be practiced according to standard techniques and materials used in the semiconductor fabrication industry. For example, the photomask 5 may be a transparent pane, such as a quartz pane, having an emulsion or metal film on a surface creating the mask pattern. Suitable metals include chromium. The pattern of the mask is chosen so that regions on the surface of the substrate can be selectively activated for polymer synthesis. Radiation, for example, ultra violet radiation (UV) or deep ultraviolet radiation (DUV), may then be directed through the photomask 5 onto the photoresist layer. The photoresist 4 is exposed in those regions of the mask that are transparent to the impinging radiation. In general, the device used for creating a pattern in the photoresist can be a physical mask or any other source capable of projecting a pattern image, for example a micromirror.
  • The exposure of the photoresist 4 to radiation generates cleaving reagents (species that catalyze the removal of a protective group, for example) in the exposed portion of the photoresist layer 4. The generation of cleaving reagents in the photoresist may be the result of a number of processes. For example, the cleaving reagent may result from the direct radiation-induced decomposition of or chemical transformation of a photoactive cleavage reagent precursor compound. Alternatively or in addition, generation of the cleaving reagent may occur through the absorption of light by a photosensitizer followed by reaction of the photosensitizer with the cleavage reagent precursor, energy transfer from the photosensitizer to the cleavage reagent precursor, or a combination of two or more different mechanisms.
  • As a result of the radiation-induced generation of the cleaving reagent, the protecting groups 3 are cleaved from the molecules 2 under the exposed area(s) of the photoresist. The molecules 2 located under the unexposed masked regions remain unreacted. The cleaving process leading to the removal of the protecting groups 3 may, for example, be acid-catalyzed cleavage or base-catalyzed cleavage. The chemistry of the process will depend on the type of protecting groups 3 and on the type of cleaving reagents that are generated in the photoresist upon radiation exposure. For example, if the protecting group 3 is t-BOC, acid cleavage can be used. Acids may be generated in the photoresist, for example, through the exposure of sulfonium or halonium salts to radiation (FIG. 2, Structures (IV-VII) and (VIII-IX), respectively). If the protecting group is FMOC, for example, then base cleavage can be used. Cleavage can be accomplished through the reaction of a photogenerated amine or diamine through a decarboxylation process (FIG. 5). The rate of protecting group removal can be accelerated by heating the substrate after the exposure to radiation (post exposure bake). The post exposure bake (PEB) serves multiple purposes in photoresist processing. First, the elevated temperature of the bake drives diffusion of the photoproducts. A small amount of diffusion can be useful in minimizing the effects of standing waves, periodic variations in exposure dose throughout the depth of the film that result from interference of incident and reflected radiation. The other main purpose of the PEB is to drive the acid-catalyzed reaction. Chemical amplification is important because it allows a single photoproduct to cause many solubility-switching reactions, thus increasing the sensitivity of these photoresist systems.
  • Subsequent to the exposure of the masked substrate to radiation, the photoresist is removed. The photoresist layer 4 may be removed using acetone or another similar suitable solvent. The resulting surface-modified substrate is shown schematically in FIG. 1D. In this structure, there are three regions shown: two regions that have protected molecules and a region having deprotected molecules. The deprotected molecules are available for further reaction, such as for example, a peptide-bond forming coupling reaction whereas the molecules that retain their protective groups are not available for further reaction. Solid phase peptide synthesis can be carried out using standard techniques, see for example, Bodansky, M., Bodansky, A., The Practice of Peptide Synthesis (2nd edition), Springer Verlag, Berlin (1995); Stewart, J. M., Young, J. D., Solid Phase Peptide Synthesis (2nd edition), Pierce Chemical Company, Rockford III., (1984); Solid-Phase Peptide Synthesis: Methods in Enzymology, vol. 298, Academic Press (1997); and for synthesis of peptides and peptidomimetics: Methods in Organic Chemistry, vol E22, Houben Weyl (2004). FIG. 1E shows a structure resulting from the reaction of the deprotected surface-attached molecules. In FIG. 1E, a building block 6 has been added to molecule 2. Building block 6 may be the same or different from molecule 2. The building block 6 is protected with a protecting group to prevent unwanted reactions.
  • The processes illustrated in FIGS. 1A-E may be repeated to form polymers on the substrate surface. Through the selection of different mask configurations, different polymers comprising building blocks 2 and 6-10 may be formed in regions upon the surface, as shown schematically in FIG. 2F. In the case where the building blocks are amino acids, peptides having the same or different known sequences are formed in known regions on the surface of the substrate. In general, polymers containing from about 2 to about 50 mers (polymeric units) can be created. In embodiments of the invention peptides having a length of about 6 to about 20 amino acids are created.
  • Any unreacted deprotected chemical functional groups may be capped at any point during a synthesis reaction to avoid or to prevent further bonding at such molecule. In general, capping reagents can be a reagent that prevents further reactivity at the site of polymer chain formation such as, for example, an acid anhydride without further reactive functionalities. Capping groups cap deprotected functional groups by, for example, binding with the unreacted amino functions to form amides. Capping agents suitable for use in an embodiment of the invention include: acetic anhydride, n-acetylimidizole, isopropenyl formate, fluorescamine, 3-nitrophthalic anhydride and 3-sulfoproponic anhydride.
  • In general, peptides are polymers of amino acids, amino acid mimics or derivatives, and/or unnatural amino acids. The amino acids can be any amino acids, including α, β, or ω-amino acids and modified amino acids. When the amino acids are α-amino acids, either the L-optical isomer or the D-optical isomer may be used. FIG. 2, Structure (I), shows a general structural representation for an amino acid. In general, an amino acid contains an amine group, a carboxylic group, and an R group. The R group can be a group found on a natural amino acid or a group that is similar in size to a natural amino acid R group. Additionally, unnatural amino acids, for example, O-alanine, phenylglycine, homoarginine, aminobutyric acid, aminohexanoic acid, aminoisobutyric acid, butylglycine, citrulline, cyclohexylalanine, diaminopropionic acid, hydroxyproline, norleucine, norvaline, ornithine, penicillamine, pyroglutamic acid, sarcosine, and thienylalanine are also contemplated by the embodiments of the invention. These and other natural and unnatural amino acids are available from, for example, EMD Biosciences, Inc., San Diego, Calif.
  • A peptide is a polymer in which the monomers are amino acids, a group of molecules which includes natural or unnatural amino acids, amino acid mimetics, and amino acid derivatives, which are generally joined together through amide (peptide) bonds. A peptide can alternatively be referred to as a polypeptide. Peptides contain two or more amino acid monomers, and often more than 50 amino acid monomers (building blocks).
  • A protein is a long polymer of amino acids linked via peptide bonds and which may be composed of one or more polypeptide chains. More specifically, the term protein refers to a molecule comprised of one or more polymers of amino acids. Proteins are essential for the structure, function, and regulation of the body's cells, tissues, and organs, and each protein has unique functions. Examples of proteins include some hormones, enzymes, and antibodies.
  • A protecting group is a group which is bound to a molecule and designed to block a reactive site in a molecule, but may be removed upon exposure to an activator or a deprotecting reagent. Deprotecting reagents include, for example, acids and bases. Protecting groups can be bound to a monomer, a polymer, a linker molecule or a monomer, or polymer, or a linker molecule attached to a solid support to protect a reactive functionality on the monomer, polymer, or linker molecule. Protective groups that may be used in accordance with an embodiment of the invention include all acid and base labile protecting groups. For example, peptide amine groups are preferably protected by t-butoxycarbonyl (t-BOC or BOC) (shown in FIG. 1, Structure (II)) or benzyloxycarbonyl (CBZ), both of which are acid labile, or by 9-fluorenylmethoxycarbonyl (FMOC) (shown in FIG. 1, Structure (III)), which is base labile.
  • Additional protecting groups that may be used in accordance with embodiments of the invention include acid labile groups for protecting amino moieties: tert-amyloxycarbonyl, adamantyloxycarbonyl, 1-methylcyclobutyloxycarbonyl, 2-(p-biphenyl)propyl(2)oxycarbonyl, 2-(p-phenylazophenylyl)propyl(2)oxycarbonyl, .alpha.,.alpha.-dimethyl-3,5-dimethyloxybenzyloxy-carbonyl, 2-phenylpropyl(2)oxycarbonyl, 4-methyloxybenzyloxycarbonyl, furfuryloxycarbonyl, triphenylmethyl(trityl), p-toluenesulfenylaminocarbonyl, dimethylphosphinothioyl, diphenylphosphinothioyl, 2-benzoyl-1-methylvinyl, o-nitrophenylsulfenyl, and 1-naphthylidene; as base labile groups for protecting amino moieties: 9-fluorenylmethyloxycarbonyl, methylsulfonylethyloxycarbonyl, and 5-benzisoazolylmethyleneoxycarbonyl; as groups for protecting amino moieties that are labile when reduced: dithiasuccinoyl, p-toluene sulfonyl, and piperidino-oxycarbonyl; as groups for protecting amino moieties that are labile when oxidized: (ethylthio)carbonyl; as groups for protecting amino moieties that are labile to miscellaneous reagents, the appropriate agent is listed in parenthesis after the group: phthaloyl(hydrazine), trifluoroacetyl(piperidine), and chloroacetyl (2-aminothiophenol); acid labile groups for protecting carboxylic acids: tert-butyl ester; acid labile groups for protecting hydroxyl groups: dimethyltrityl. See also, Greene, T. W. Protective Groups in Organic Synthesis, Wiley-Interscience, NY, (1981).
  • A linker molecule typically is a molecule inserted into the growing polymer that does not necessarily convey functionality to the resulting peptide, such as molecular recognition functionality, but instead elongates the distance between the substrate surface and the peptide functionality to enhance the exposure of the peptide functionality on the surface of the substrate. Preferably a linker should be about 4 to about 40 atoms long to provide exposure. The linker molecules may be, for example, aryl acetylene, ethylene glycol oligomers containing 2-10 monomer units (PEGs), diamines, diacids, amino acids, among others, and combinations thereof. Examples of diamines include ethylene diamine and diamino propane. Alternatively, the linkers may be the same molecule type as that being synthesized (i.e., nascent polymers), such as polypeptides and polymers of amino acid derivatives such as for example, amino hexanoic acids.
  • Solid support, support, and substrate refer to a material or group of materials having a rigid or semi-rigid surface or surfaces. In some aspects, at least one surface of the solid support will be substantially flat, although in some aspects it may be desirable to physically separate synthesis regions for different molecules with, for example, wells, raised regions, pins, etched trenches, or the like. In certain embodiments, the solid support may be porous.
  • Substrate materials useful in embodiments of the present invention include, for example, silicon, bio-compatible polymers such as, for example poly(methyl methacrylate) (PMMA) and polydimethylsiloxane (PDMS), glass, SiO2 (such as, for example, a thermal oxide silicon wafer such as that used by the semiconductor industry), quartz, silicon nitride, functionalized glass, gold, platinum, and aluminum. Functionalized surfaces include for example, amino-functionalized glass, carboxy functionalized glass, and hydroxy functionalized glass. Additionally, a substrate may optionally be coated with one or more layers to provide a surface for molecular attachment or functionalization, increased or decreased reactivity, binding detection, or other specialized application. Substrate materials and or layer(s) may be porous or non-porous. For example, a substrate may be comprised of porous silicon. Additionally, the substrate may be a silicon wafer or chip such as those used in the semiconductor device fabrication industry. In the case of a wafer or chip, a plurality of arrays may be synthesized on the wafer.
  • Photoresist formulations useful in the present invention include a polymer, a solvent, and a radiation-activated cleaving reagent. Useful polymers include, for example, poly(methyl methacrylate) (PMMA), poly-(methyl isopropenyl ketone) (PMPIK), poly-(butene-1-sulfone) (PBS), poly-(trifluoroethyl chloroacrylate) (TFECA), copolymer-(α-cyano ethyl acrylate-α-amido ethyl acrylate (COP), and poly-(2-methyl pentene-1-sulfone). Useful solvents include, for example, propylene glycol methyl ether acetate (PGMEA), ethyl lactate, and ethoxyethyl acetate. The solvent used in fabricating the photoresist may be selected depending on the particular polymer, photosensitizer, and photo-active compound that are selected. For example, when the polymer used in the photoresist is PMMA, the photosensitizer is isopropyl-thioxanthenone, and the photoactive compound is diphenyliodonium chloride, PGMEA or ethyl lactate may be used as the solvent.
  • In exemplary photoresist formulations, the mass concentration of the polymer may between about 5% and about 50%, the mass concentration of a photosensitizer may be up to about 20%, the mass concentration of the photo-active compound may be between about 1% and 10%, the balance comprising a suitable solvent. After the photoresist is deposited on the substrate, the substrate typically is heated to form the photoresist layer. Any method known in the art of semiconductor fabrication may be used to for depositing the photoresist solution. For example, the spin coating method may be used in which the substrate is spun typically at speeds between about 1,000 and about 5,000 revolutions per minute for about 30 to about 60 seconds. The resulting wet photoresist layer has a thickness ranging between about 0.1 μm to about 2.5 μm.
  • Catalysts for protective group removal (also referred to as cleaving reagents) useful in the present invention include acids and bases. For example, acids can be generated photochemically from sulfonium salts (FIG. 2, Structures IV-VII), halonium salts (FIG. 2, Structures VIII-IX), and polonium salts (FIG. 2, Structures X-XI). Sulfonium ions are positive ions, R3S+, where R is, for example, a hydrogen or alkyl group, such as methyl, phenyl, or other aryl group. Trimethyl sulfonium iodide and triaryl sulfonium hexafluoroantimonatate (TASSbF6) are shown in FIG. 2, Structures VII and VI, respectively. In general, halonium ions are bivalent halogens, R2X+, where R is a hydrogen or an alkyl group, such as methyl, phenyl, or other aryl group, and X is a halogen atom. The halonium ion may be linear or cyclic. Polonium salt refers to a halonium salt where the halogen is iodine, the compound R2I+Y, where Y is an anion, for example, a nitrate, chloride, or bromide. FIG. 2 shows diphenyliodonium chloride and diphenyliodonium nitrate (Structure X and XI, respectively). See also, Frechet, J. M. J., Ito, H., Willson, C. G., Proc. Microcircuit Eng., 260, (1982); Shirai, M., Tsunooka, M., Prog. Polym. Sci., 21:1, (1996); Frechet, J. M. J., Eichler, E, Ito, H., Willson, C. G., Polymer, 24:995, (1983); and Frechet, J. M. J., Ito, H., Willson, C. G., Tessier, T. G., Houlihan, F. M. J., J. of Electrochem. Soc., 133:181 (1986).
  • Photogenerated bases include amines and diamines having photolabile protecting groups. See for example, Shirai, M., Tsunooka, M., Prog. Polym. Sci., 21:1, (1996); Comeron, J. F., Frechet, J. M. J., J. Org. Chem., 55:5919, (1990); Comeron, J. F., Frechet, J. M. J., J. Am. Chem. Soc., 113:4303, (1991); and Arimitsu, K. and Ichimura, K., J. Mat. Chem., 14:336, (2004).
  • Optionally, the photoresists useful in the present invention may also include a photosensitizer. In general, a photosensitizer absorbs light and interacts with the cleavage reagent precursor, through one or more mechanisms, including, reaction with the cleavage reagent precursor and energy transfer from the photosensitizer to the cleavage reagent precursor. Useful photosensitizers include, for example, benzophenone (FIG. 2, Structure XII) and other similar diphenyl ketones, thioxanthenone (FIG. 2, Structure XIII), isopropyl-thioxanthenone, anthraquinone, fluorenone, acetophenone, and perylene.
  • FIG. 3 provides a method for derivatization of a SiO2 surface and linking of polymeric molecules to the surface. In FIG. 3 the SiO2 surface is silanated by reacting it with aminopropyltriethoxy silane (APTES). The resulting surface presents an amine functional group for further reaction, such as peptide bond formation. Modulation of the density of polymers on the surface can be attained by silanation. For example, density can be modulated by mixing a functionalizable silane for example. APTES, with a non-functional silane (a silane with no non silyl functional group), for example, propyltrialkoxy silane. The derivatized surface can then be reacted with a linker. In this example, the linker is a polyethylene glycol molecule having an amine group protected with BOC at one terminus and a peptide-bond forming group (a carboxyl group) at the second terminus. This coupling reaction can be accomplished in a solution of carboxyl group activators: 1-hydroxybenzotriazole (HOBt) and diisopropylcarbodiimide (DIC) in N-methylpyrrolidone (NMP). The linker molecule serves to separate polymer (peptide) that is subsequently synthesized from surface of the substrate.
  • FIG. 4 shows a general scheme for solid-phase peptide synthesis. A substrate surface is provided having a first amino acid attached to the surface. A second amino acid having an amino protecting group is coupled to the first amino acid. In this example, the second amino acid is N-protected with a BOC protecting group. The coupling reaction is performed in a solution of 1-hydroxybenzotriazole (HOBt) and diisopropylcarbodiimide (DIC) in N-methylpyrrolidone (NMP). Unreacted amine groups are capped using an acetic anhydride (Ac2O) solution in dimethylformamide (DMF). The substrate surface is then coated with a photoresist. In this example, the photoresist is comprised of PMMA polymer, TASSbF6 (photoactivated acid generator), and PGMEA (as a solvent). (In FIG. 4, TFA represents trifluoroacetic acid, the acidic cleaving reagent typically used for bulk solid-phase peptide synthesis. Experiments demonstrated that yields for a peptide synthesis process according to the current invention were similar to yields for bulk solid-phase synthesis procedures using TFA as a protecting group removal catalyst.) Upon exposure to radiation, in this case UV radiation, an acid is produced in the photoresist and the N-protecting group is removed from the attached peptide in the region of UV exposure. By repeating the process shown in FIG. 4, peptides of desired sequence and length in selected regions upon the substrate surface can be produced.
  • FIG. 5 diagrams a method for using semiconductor photoresist acid and base cleavage mechanisms and orthogonal protection chemistries to create a branch point in a growing solid-phase polymer chain. In FIG. 5, a region of a substrate surface presents an attached amino acid building block containing an acid-cleavable protecting group that prevents the formation of a peptide bond. As described herein, the amino acid building block may be attached to the surface through a linker molecule that spaces the amino acid from the surface and or that functions as a peptide or peptidemimetic. The substrate surface is coated with an acid-generating photoresist and at least one region of the substrate surface is exposed to radiation to induce the formation of the photo-generated acid in the photoresist. A mask is used to selectively block the radiation from areas of the substrate surface and thereby cause deprotection of only molecules located in selected regions of the substrate surface. Preferably, the substrate surface is subjected to a post-exposure bake. The photoresist is then stripped from the substrate surface leaving a section(s) of the substrate having deprotected sites available for the formation of peptide bonds. A bifurcation group is coupled to the deprotected growing chain. The bifurcation group contains both acid and base cleavable protecting groups. The branch points of the bifurcation group can be selectively deprotected by selecting either an acid or a base-generating photoresist. In the scheme shown in FIG. 5, a base-generating photoresist is selected and the base-cleavable protecting group is removed from the bifurcation group upon irradiation. The surface is baked and the resist removed. An amino acid having a base-removable protecting group is coupled to the bifurcation group at the point in which the base-removable group was removed. Alternatively or subsequently, the acid labile protecting group may be removed in a similar manner using a photoresist containing a photogenerated acid as described herein. An amino acid having an acid-removable protecting group is then coupled to the bifurcation group. Repetitions of these acid or base deprotection-coupling events allow a branched polymer having a desired sequence to be synthesized. The polymers formed from the branch-point may be the same or different lengths. Additionally, optionally polymers having one or more branch points may be created. An array may be created having both branched and unbranched polymers in regions upon its surface.
  • In general, a bifurcation molecule is a molecule that when it is attached to a growing polymer provides more than one location for further polymer growth or extension. In other words, a bifurcation molecule is a polymeric building block that creates a branch point in a polymer. FIGS. 6A-C provide several exemplary bifurcation molecules: FIG. 6A shows Trt-Dpr(Fmoc)-OH (Dpr is diaminopropionic acid); FIG. 6B shows Fmoc-Dab(Mtt)-OH (“Dab” is diaminobutanoic acid, “Mtt” is 4-methyltrityl, an acid-removable protecting group); FIG. 6C shows Fmoc-Glu-OTMSEt (“OTMSEt” is trimethylsilylethanol). Additional examples of useful bifurcation molecules include Fmoc-Dpr(Boc)-OH, Fmoc-Dab(Boc)-OH, or any of the previous amino acids having the same protecting group at the amino and the side chain functionalities (to allow growth of two peptide chains having the same sequence), such as for example, Fmoc-Dpr(Fmoc)-OH or Trt-Dpr(Trt)-OH. Many bifurcation molecules are available from EMD Biosciences Nova Biochem, La Jolla, Calif.; Bachem, Torrance, Calif.; and Chem-Impex International.
  • FIG. 7 diagrams a further method by which branch points can be created in a polymer using orthogonal protection strategies and solid-phase bio-polymer synthesis. In FIG. 7, direct photo-cleavage lithography is applied to the synthesis of a branched peptide array. In this example, a region of a substrate surface presents an attached amino acid building block containing a photo-cleavable protecting group that prevents the formation of a peptide bond. As described herein, the amino acid building block may be attached to the surface through a linker molecule that spaces the amino acid from the surface and or that functions as a peptide or peptidemimetic. The photo-cleavable protecting group is removable at a first wavelength, λ1. Exposing the substrate through a mask to radiation at a first wavelength, λ1, removes the protecting group in selected regions. A bifurcation group having photo-cleavable protecting groups that are removable at two different wavelengths, λ1 and λ2, is coupled to the photo-deprotected amino acid building blocks. In the example of FIG. 7, a selected area(s) of the substrate surface are exposed to light of wavelength λ2 and the λ2 photo-removable protecting group is removed. An amino acid building block having a λ2 photo-removable protecting group is coupled to the deprotected site of the bifurcation group. Alternately or subsequently, a selected area(s) of the substrate surface are exposed to light of wavelength λ1 and the λ1 photo-removable protecting group is removed. An amino acid building block having a λ1 photo-removable protecting group is coupled to the deprotected site of the bifurcation group. Repetitions of these photo-deprotection-coupling events allow a branched polymer having a desired sequence to be synthesized. The polymers formed from the branch-point may be the same or different lengths. Additionally, optionally polymers having one or more branch points may be created. An array may be created having both branched and unbranched polymers in regions upon its surface.
  • Some examples of wavelength controlled orthogonal protecting groups are described in “Wavelength-Controlled Orthogonal Photolysis of Protecting Groups,” Blanc, A. and Bochte, C., J. Org. Chem., 67:5567 (2002). Additional examples of photo-cleavable protecting groups can be found in: Photogenerated Reagents in Biochemistry and Molecular Biology, Bayley, H., Laboratory Techniques in Biochemistry and Molecular Biology, 12, Elsevier (2002); and Clark, M. A. and Romoff, T. T., Synthesis of peptides and peptidomimetics, Methods of Organic Chemistry, E22a:276 (2004). The most common photocleavable groups are 2-nitrobenzyl-derived carbamates, esters, and ethers. Examples include Z(2-NO2), Nvoc, Ndmoc, Dnboc, Menpoc, Ddz. Other examples include tosyl, phenacyl-based esters, and the 5-bromo-7-nitro-indolinyl group. Many amino acids with photocleavable protecting groups are available from Chem-Impex International, Wood Dale, Ill.
  • In further embodiments of the present invention, methods are provided to synthesize biopolymers on an array wherein the synthesis is assisted by microwave radiation. Organic synthesis reactions that are assisted by microwave radiation generally demonstrate faster rates and improved fidelity. Synthesis of biopolymers, particularly parallel synthesis methodologies can encounter difficulties, depending on the species being synthesized, from intermolecular aggregation, hydrogen bonded secondary structures (such as, for example, beta-sheet formation in peptides), steric hindrance from bulky side chain protecting groups, and hence premature termination of the sequence. Referring now to FIG. 8, a schematic is presented showing the microwave heating of polymers on a substrate surface. In this example, the heating of the polymers causes them to unwind. In the microwave-assisted solid phase synthesis of polymer chains, microwave energy directly activates any molecule with a dipole moment and allows for local heating at a molecular level. Thus, intermolecular and intramolecular aggregation, secondary structure formation, and steric hindrance can be overcome with microwave energy. Additionally, by using microwave energy in conjunction with parallel synthesis methods, reaction times for deprotection and coupling reactions can be reduced and fidelity of lithographic techniques can be enhanced.
  • FIG. 9 shows the use of microwave energy to assist the synthesis of biopolymers on a solid support. In general, microwave energy can be used to facilitate the synthesis of branched and unbranched biopolymers, such as for example, peptides, peptidemimetics, and polynucleotides, by photoresist methods and methods employing photo-removable protecting groups, as described herein and as known in the art. The term polynucleotide includes oligonucleotides, peptide nucleic acids (PNAs), and cDNA. In FIG. 9, a substrate surface presents attached biopolymer building blocks having a protecting group that prevents polymer formation. The substrate is coated with a photoresist. Selected areas of the substrate are exposed to radiation through a mask to remove the protecting group in the presence of microwave energy. The photoresist is removed and a second building block having a protecting group is coupled to the first deprotected building block. These steps are repeated for form desired polymers, in this case the polymers are peptides, at desired locations on the substrate surface. Synthesizers generally supply microwave power of about 25 to 50 W and a temperature range of 20 to 70° C. Additionally, microwave energy can be employed in the manufacture of arrays on silicon chips. In this case a microwave stepper and a microwave synthesizer can be used to manufacture a plurality of arrays in a similar manner as it is employed in the semiconductor fabrication industry.
  • EXAMPLE 1
  • A glass substrate was silanated using a solution of 3% APTES (aminopropyl triethoxy silane) in 95% ethanol. The surface of the substrate was then washed and annealed at about 100° C. for about 1 hour. The substrate was then treated with a 1:1 solution of DIEA (diisopropyl ethyl amine) in DMF (dimethylformamide). A spacer molecule was then coupled to the surface using a solution of 0.25 M solution of O—(N-Boc-2-aminoethyl)-O′—(N-diglycolyl-2-aminoethyl) hexaethyleneglycol, 0.25 M HOBt, and 0.25 M DIC (diisopropylcarbodiimide) in NMP (N-methyl pyrrolidone) and gentle agitation over the surface of the substrate in a sealed container for about 30 min. The solution was then discarded and the surface replenished with fresh solution. After coupling was complete, the surface was washed with NMP and then acetone. Unreacted surface amine groups were capped by treatment with 1:1 acetic anhydride in DMF solution (a 50% acetic anhydride solution in DMF) for about 30 minutes. The surface was then washed.
  • A photoresist was prepared by mixing about 10% by mass of PMMA, 20% by mass of triarylsulfonium hexafluoroantimonate in PGMEA solvent and spin coating the mixture over the amino acid derivatized glass surface for about 60 seconds at 2,000 rpm. The photoresist may also optionally contain thioxanthenone, a photosensitizer. The photoresist layer was baked at about 85° C. for about 90 seconds. The resulting photoresist layer had a thickness of about 2 μm.
  • Acid was generated in the photoresist layer by irradiation of the surface of the substrate with 2-3 J of 365 nm UV light through a mask. The reaction was accelerated by a post exposure bake at about 65° C. for about 60 seconds. After the photogenerated acid deprotection was achieved, the surface of the substrate was rinsed with acetone to strip the photoresist from the surface and the surface was dried. The surface was neutralized by treatment in 25% DIEA/DMF for about 5-10 minutes and then washed in DMF.
  • A second amino acid (Boc-Leu-OH) was coupled to the surface of the substrate using a 0.25 M solution of N-α-Boc-Leu, HOBt, and DIC as above. Subsequent rounds of coupling and deprotection were accomplished by repeating the above procedures to generate peptides of a desired length. As a result, a hexamer peptide, SDLYKL segment of human tumor suppressor protein p53, was synthesized on an APTES surface derivatized with a PEG (polyethylene glycol) spacer. A labeled F1-tagged anti-p53 monoclonal antibody in a standard Ab binding assay recognized and strongly bound to the SDLYLK peptide on the surface as determined by fluorescence detection.
  • EXAMPLE 2
  • An array of wildtype (SDLHKL) and mutant (AGLHKL) peptide was synthesized on an aminated glass surface with a linker molecule, O—(N-Boc-2-aminoethyl)-O′—(N-diglycolyl-2-aminoethyl) hexaethyleneglycol, for spacing the peptides from the surface. The peptides were synthesized in a checkerboard pattern using uniform photodeprotection of t-Boc protecting groups through an open grid mask till the second leucine and spatially localized deprotection through a checkerboard mask for the last two amino acid couplings.
  • The photodeprotection and coupling of linker molecules and amino acids was carried out as described in Example 1.
  • The peptide array was incubated for 1 hour with 5 μg/ml monoclonal antibody known to specifically recognize the SDLHKL epitope of human p53 protein. A second incubation was performed with fluorescein-labeled rabbit antibody raised against mouse antibody at a 1:100 dilution in phosphate buffered saline with 0.05% Tween 20. A fluorescent checker board pattern was detected on fluorescence scanning of the array suggesting specific interaction of antibody with the wildtype sequence.
  • EXAMPLE 3
  • Photoresist formulations may include a sensitizer in addition to the photogenerated acid catalyst to generate the acid deprotection catalysts. In general, the amount of PMMA in the resist in these exemplary formulations may vary between about 3% and about 50%.
  • Useful photoresists may be made using diaryliodonium salts (DAI) and photosensitizers. The mass ration between DAI and photosensitizer may be between about 1:10 and 1:1. For instance, (tolylcumyl)polonium tetrakis(pentafluorophenyl) borate with isopropyl-9H-thioxanthen-9-one may be formulated in a 1:10 or 1:1 (or a ratio there between) in PMMA and PGMEA to form final concentrations of between about 0.5% to 10% by mass DAI. The formulation selected may be spun coated on the substrate surface and baked. The radiation exposure dose may be between about 0.02 J and about 10 J. Post exposure baking may be conducted for about 30 to 60 seconds at about 40° C. to about 85° C.

Claims (15)

1-30. (canceled)
31. A method for making an array of polymers comprising, attaching to a substrate surface a first molecule capable of forming a peptide bond wherein the molecule contains a first functional group capable of attaching to the surface of the substrate, a second functional group capable of forming a peptide bond, and a protecting group that prevents the formation of a peptide bond by the second functional group,
depositing a photosensitive layer over the substrate surface wherein the photosensitive layer contains a photo-active compound that upon activation generates a second compound capable of causing the removal of the protecting group,
exposing a portion of the substrate surface to both ultraviolet and microwave radiation wherein ultraviolet radiation exposure causes the removal of protecting groups,
removing the photosensitive layer, and
coupling a second molecule capable of forming a peptide bond, wherein the molecule contains a first functional group capable of forming a peptide bond with the first molecule, a second functional group capable of forming a peptide bond, and a protecting group that prevents the formation of a peptide bond by the second functional group, to the first molecule capable of forming a peptide bond that has been deprotected.
32. The method according to claim 31 also including baking the substrate after exposing a portion of the substrate surface to ultraviolet radiation.
33. The method according to claim 31 also including capping unreacted peptide bond-forming sites on the first molecule capable of forming a peptide bond after coupling the second molecule capable of forming a peptide bond.
34. The method according to claim 31 wherein attaching is accomplished through the formation of a peptide bond.
35. The method according to claim 31 wherein the second compound capable of causing the removal of the protecting group is a photogenerated acid or base.
36. The method according to claim 31 wherein the second compound capable of causing the removal of the protecting group is a photogenerated acid and the photo-active compound is selected from the group consisting of sulfonium salts, halonium salts, and polonium salts.
37. The method according to claim 31 wherein the substrate surface to which the first molecule capable of forming a peptide bond is attached is an amino-functionalized SiO2 surface.
38. The method according to claim 37 wherein the substrate is comprised of silicon having a layer of SiO2 on the surface.
39. The method according to claim 31 wherein the photosensitive layer comprises a polymer, a photo-active compound, and a solvent.
40. The method according to claim 31 wherein the photosensitive layer additionally includes a photosensitizer.
41. The method according to claim 40 wherein the photosensitizer is selected from the group consisting of benzophenones, thioxanthenones, anthraquinone, fluorenone, acetophenone, and perylene.
42. The method of claim 40 wherein a molecule capable of forming a peptide bond is a spacer molecule selected from the group consisting of aryl acetylenes, polyethyleneglycols, nascent polypeptides, diamines, diacids, peptides, and combinations thereof.
43. The method of claim 42 wherein the protecting group is t-butoxycarbonyl, benzyloxycarbonyl, or 9-fluorenylmethoxycarbonyl.
44-54. (canceled)
US12/133,219 2005-12-29 2008-06-04 Massively parallel synthesis of biopolymeric arrays Abandoned US20080242561A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/133,219 US20080242561A1 (en) 2005-12-29 2008-06-04 Massively parallel synthesis of biopolymeric arrays

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/322,268 US20070154946A1 (en) 2005-12-29 2005-12-29 Massively parallel synthesis of biopolymeric arrays
US12/133,219 US20080242561A1 (en) 2005-12-29 2008-06-04 Massively parallel synthesis of biopolymeric arrays

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/322,268 Division US20070154946A1 (en) 2005-12-29 2005-12-29 Massively parallel synthesis of biopolymeric arrays

Publications (1)

Publication Number Publication Date
US20080242561A1 true US20080242561A1 (en) 2008-10-02

Family

ID=38008220

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/322,268 Abandoned US20070154946A1 (en) 2005-12-29 2005-12-29 Massively parallel synthesis of biopolymeric arrays
US12/133,260 Abandoned US20090258796A1 (en) 2005-12-29 2008-06-04 Massively parallel synthesis of biopolymeric arrays
US12/133,190 Expired - Fee Related US9499578B2 (en) 2005-12-29 2008-06-04 Massively parallel synthesis of biopolymeric arrays
US12/133,219 Abandoned US20080242561A1 (en) 2005-12-29 2008-06-04 Massively parallel synthesis of biopolymeric arrays

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US11/322,268 Abandoned US20070154946A1 (en) 2005-12-29 2005-12-29 Massively parallel synthesis of biopolymeric arrays
US12/133,260 Abandoned US20090258796A1 (en) 2005-12-29 2008-06-04 Massively parallel synthesis of biopolymeric arrays
US12/133,190 Expired - Fee Related US9499578B2 (en) 2005-12-29 2008-06-04 Massively parallel synthesis of biopolymeric arrays

Country Status (4)

Country Link
US (4) US20070154946A1 (en)
EP (1) EP1966230B1 (en)
AT (1) ATE509940T1 (en)
WO (1) WO2007078868A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080318808A1 (en) * 2005-12-29 2008-12-25 Rajasekaran John J Massively parallel synthesis of biopolymeric arrays

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332273B2 (en) * 2002-06-20 2008-02-19 Affymetrix, Inc. Antireflective coatings for high-resolution photolithographic synthesis of DNA arrays
US20070275411A1 (en) 2006-05-25 2007-11-29 Mcgall Glenn H Silane mixtures
US20100240544A1 (en) * 2006-09-29 2010-09-23 Liu David J Aptamer biochip for multiplexed detection of biomolecules
US9096953B2 (en) * 2006-09-29 2015-08-04 Intel Corporation Method for high throughput, high volume manufacturing of biomolecule micro arrays
US8614086B2 (en) 2006-12-28 2013-12-24 Intel Corporation Quality control methods for the manufacture of polymer arrays
US7923237B2 (en) * 2006-12-28 2011-04-12 Intel Corporation Method and apparatus for combined electrochemical synthesis and detection of analytes
US20080160446A1 (en) * 2006-12-28 2008-07-03 Meagley Robert P Photoresists including amino acid polymers as photoimageable species
US20100248975A1 (en) * 2006-12-29 2010-09-30 Gunjan Tiwari Fluorogenic peptide substrate arrays for highly multiplexed, real-time monitoring of kinase activities
US20080161202A1 (en) * 2006-12-29 2008-07-03 Edelmira Cabezas Novel strategy for selective regulation of background surface property in microarray fabrication and method to eliminated self quenching in micro arrays
WO2008151146A2 (en) * 2007-06-01 2008-12-11 Digitab, Inc. Peptide arrays and methods of use
GB201000879D0 (en) * 2010-01-20 2010-03-10 Univ Reading The Improved hydrogel synthesis
US10427125B2 (en) 2011-05-09 2019-10-01 Arizona Board Of Regents On Behalf Of Arizona State University Methods for performing patterned chemistry
JP6012767B2 (en) 2012-02-07 2016-10-25 ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー Substrates, peptide arrays, and methods
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
EP2901159B1 (en) 2012-09-28 2020-02-26 Vibrant Holdings, LLC Methods, systems, and arrays for biomolecular analysis
US10046293B2 (en) 2012-10-17 2018-08-14 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona In situ chemical patterning
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
CA3027054C (en) 2012-11-14 2023-02-07 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
JP5981667B2 (en) 2013-02-15 2016-08-31 ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー Methods and compositions for amplified electrochemiluminescence detection
US9605344B2 (en) 2013-09-15 2017-03-28 Stc.Unm Method for atomic layer deposition
JP6619362B2 (en) 2014-02-21 2019-12-11 ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー Selective photoactivation of amino acids for one-step peptide coupling
US20180106795A1 (en) * 2015-03-12 2018-04-19 Vibrant Holdings, Llc Polypeptide arrays and methods of attaching polypeptides to an array
US10758886B2 (en) 2015-09-14 2020-09-01 Arizona Board Of Regents On Behalf Of Arizona State University Conditioned surfaces for in situ molecular array synthesis
KR102632268B1 (en) * 2016-01-11 2024-01-31 삼성전자주식회사 Photo resist composition and method of manufacturing a semiconductor device using the same
CN106117453A (en) * 2016-06-08 2016-11-16 广州高通生物技术有限公司 A kind of macromolecule mother solution and the manufacture method of 3D biochip
US10538808B2 (en) 2017-05-26 2020-01-21 Vibrant Holdings, Llc Photoactive compounds and methods for biomolecule detection and sequencing
US11420941B2 (en) 2017-06-29 2022-08-23 Cowper Sciences Inc. Methods and systems for mask alignment in manufacturing process of arrays
EP3790985A4 (en) 2018-05-09 2022-02-16 Vibrant Holdings, LLC Methods of synthesizing a polynucleotide array using photactivated agents
US11517873B2 (en) 2019-10-29 2022-12-06 International Business Machines Corporation Controlled chemical synthesis using polymer substrates and nanofluidic separation systems

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767398A (en) * 1971-10-26 1973-10-23 C Morgan Solid photoresist comprising a polyene and a polythiol
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6121048A (en) * 1994-10-18 2000-09-19 Zaffaroni; Alejandro C. Method of conducting a plurality of reactions
US6239273B1 (en) * 1995-02-27 2001-05-29 Affymetrix, Inc. Printing molecular library arrays
US6379895B1 (en) * 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6406844B1 (en) * 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6444111B1 (en) * 1996-07-05 2002-09-03 Combimatrix Corporation Electrochemical solid phase synthesis of polymers
US6506558B1 (en) * 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
US6515039B1 (en) * 1998-08-28 2003-02-04 Poly-An Gmbh Method for the parallel and combinatory synthesis of compounds bound to a continuous polymeric solid phase supporting material
US6566495B1 (en) * 1989-06-07 2003-05-20 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6770436B1 (en) * 1996-11-14 2004-08-03 Affymetrix, Inc. Chemical amplification for the synthesis of patterned arrays
US20040198637A1 (en) * 2002-12-22 2004-10-07 The Scripps Research Institute Protein arrays
US6819843B1 (en) * 1999-05-14 2004-11-16 Epigenomics Ag Device and method for photolithographically irradiating biological substances
US20050026202A1 (en) * 2000-09-27 2005-02-03 Edman Carl F. Electronic systems and component devices for macroscopic and microscopic molecular biological reaction, analyses, and diagnostics
US6919181B2 (en) * 2002-03-25 2005-07-19 Agilent Technologies, Inc. Methods for generating ligand arrays
US6919211B1 (en) * 1989-06-07 2005-07-19 Affymetrix, Inc. Polypeptide arrays
US20100035771A1 (en) * 2006-12-19 2010-02-11 Edelmira Cabezas Molecular microarrays and helical peptides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5959098A (en) * 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process
CN1158066C (en) * 1998-12-08 2004-07-21 弗门尼舍有限公司 Transparent perfume compsn.
DE19925372A1 (en) * 1999-06-02 2000-12-07 Bosch Gmbh Robert Method for electronically monitoring and controlling a process for moving parts
KR20010001577A (en) * 1999-06-07 2001-01-05 윤종용 Process for Preparing Oligopeptidenucleotide Probe Using Polymeric Photoacid Generator
US7348182B2 (en) * 2000-10-03 2008-03-25 Mirari Biosciences, Inc. Directed microwave chemistry
US20030044798A1 (en) 2001-08-31 2003-03-06 Lefkowitz Steven M. Methods for generating ligand arrays via deposition of ligands onto olefin displaying substrates, and arrays produced thereby
US7779026B2 (en) * 2002-05-03 2010-08-17 American Power Conversion Corporation Method and apparatus for collecting and displaying network device information
US7202358B2 (en) 2002-07-25 2007-04-10 Agilent Technologies, Inc. Methods for producing ligand arrays
CN1905893A (en) * 2003-12-05 2007-01-31 西北大学 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
US20070034513A1 (en) 2005-03-25 2007-02-15 Combimatrix Corporation Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array
US20070154946A1 (en) * 2005-12-29 2007-07-05 Rajasekaran John J Massively parallel synthesis of biopolymeric arrays

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767398A (en) * 1971-10-26 1973-10-23 C Morgan Solid photoresist comprising a polyene and a polythiol
US6919211B1 (en) * 1989-06-07 2005-07-19 Affymetrix, Inc. Polypeptide arrays
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5405783A (en) * 1989-06-07 1995-04-11 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of an array of polymers
US6630308B2 (en) * 1989-06-07 2003-10-07 Affymetrix, Inc. Methods of synthesizing a plurality of different polymers on a surface of a substrate
US6566495B1 (en) * 1989-06-07 2003-05-20 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6379895B1 (en) * 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6406844B1 (en) * 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6416952B1 (en) * 1989-06-07 2002-07-09 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6506558B1 (en) * 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
US6121048A (en) * 1994-10-18 2000-09-19 Zaffaroni; Alejandro C. Method of conducting a plurality of reactions
US6239273B1 (en) * 1995-02-27 2001-05-29 Affymetrix, Inc. Printing molecular library arrays
US6444111B1 (en) * 1996-07-05 2002-09-03 Combimatrix Corporation Electrochemical solid phase synthesis of polymers
US6770436B1 (en) * 1996-11-14 2004-08-03 Affymetrix, Inc. Chemical amplification for the synthesis of patterned arrays
US6515039B1 (en) * 1998-08-28 2003-02-04 Poly-An Gmbh Method for the parallel and combinatory synthesis of compounds bound to a continuous polymeric solid phase supporting material
US6819843B1 (en) * 1999-05-14 2004-11-16 Epigenomics Ag Device and method for photolithographically irradiating biological substances
US20050026202A1 (en) * 2000-09-27 2005-02-03 Edman Carl F. Electronic systems and component devices for macroscopic and microscopic molecular biological reaction, analyses, and diagnostics
US6919181B2 (en) * 2002-03-25 2005-07-19 Agilent Technologies, Inc. Methods for generating ligand arrays
US20040198637A1 (en) * 2002-12-22 2004-10-07 The Scripps Research Institute Protein arrays
US20100035771A1 (en) * 2006-12-19 2010-02-11 Edelmira Cabezas Molecular microarrays and helical peptides

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080318808A1 (en) * 2005-12-29 2008-12-25 Rajasekaran John J Massively parallel synthesis of biopolymeric arrays
US20090258796A1 (en) * 2005-12-29 2009-10-15 Rajasekaran John J Massively parallel synthesis of biopolymeric arrays
US9499578B2 (en) 2005-12-29 2016-11-22 Intel Corporation Massively parallel synthesis of biopolymeric arrays

Also Published As

Publication number Publication date
ATE509940T1 (en) 2011-06-15
EP1966230B1 (en) 2011-05-18
EP1966230A1 (en) 2008-09-10
US9499578B2 (en) 2016-11-22
US20080318808A1 (en) 2008-12-25
US20070154946A1 (en) 2007-07-05
WO2007078868A1 (en) 2007-07-12
US20090258796A1 (en) 2009-10-15

Similar Documents

Publication Publication Date Title
US9499578B2 (en) Massively parallel synthesis of biopolymeric arrays
US7622295B2 (en) Molecular microarrays and helical peptides
US20070122841A1 (en) Massively parallel synthesis of proteinaceous biomolecules
US20070122842A1 (en) Massively parallel synthesis of proteinaceous biomolecules
US20230294063A1 (en) Substrates, peptide arrays, and methods
US10577391B2 (en) Selective photoactivation of amino acids for single step peptide coupling
US9096953B2 (en) Method for high throughput, high volume manufacturing of biomolecule micro arrays
EP3268740B1 (en) Polypeptide arrays and methods of attaching polypeptides to an array

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION